The Discounted Cash Flow (DCF) valuation of Vanda Pharmaceuticals Inc (VNDA) is (19.47) USD. With the latest stock price at 4.86 USD, the upside of Vanda Pharmaceuticals Inc based on DCF is -500.7%.
Based on the latest price of 4.86 USD and our DCF valuation, Vanda Pharmaceuticals Inc (VNDA) is a sell. selling VNDA stocks now will result in a potential gain of 500.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 8.2% | 6.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (90.26) - (10.61) | (19.47) |
| Upside | -1957.3% - -318.4% | -500.7% |